These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 2128958)
1. Antigen restriction and IgG subclasses among anti-GBM autoantibodies. Segelmark M; Butkowski R; Wieslander J Nephrol Dial Transplant; 1990; 5(12):991-6. PubMed ID: 2128958 [TBL] [Abstract][Full Text] [Related]
2. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. Kalluri R; Wilson CB; Weber M; Gunwar S; Chonko AM; Neilson EG; Hudson BG J Am Soc Nephrol; 1995 Oct; 6(4):1178-85. PubMed ID: 8589284 [TBL] [Abstract][Full Text] [Related]
3. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen. Savige JA; Gallicchio M Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225 [TBL] [Abstract][Full Text] [Related]
4. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Cui Z; Wang HY; Zhao MH Kidney Int; 2006 Mar; 69(5):894-9. PubMed ID: 16518348 [TBL] [Abstract][Full Text] [Related]
5. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Hellmark T; Johansson C; Wieslander J Kidney Int; 1994 Sep; 46(3):823-9. PubMed ID: 7527877 [TBL] [Abstract][Full Text] [Related]
7. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen. Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555 [TBL] [Abstract][Full Text] [Related]
8. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays. Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504 [TBL] [Abstract][Full Text] [Related]
9. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen. Neilson EG; Kalluri R; Sun MJ; Gunwar S; Danoff T; Mariyama M; Myers JC; Reeders ST; Hudson BG J Biol Chem; 1993 Apr; 268(12):8402-5. PubMed ID: 8473281 [TBL] [Abstract][Full Text] [Related]
10. Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers. Olaru F; Wang XP; Luo W; Ge L; Miner JH; Kleinau S; Geiger XJ; Wasiluk A; Heidet L; Kitching AR; Borza DB J Immunol; 2013 Feb; 190(4):1424-32. PubMed ID: 23303673 [TBL] [Abstract][Full Text] [Related]
11. Production and characterization of recombinant Goodpasture antigen in insect cells. Turner N; Forstová J; Rees A; Pusey CD; Mason PJ J Biol Chem; 1994 Jun; 269(25):17141-5. PubMed ID: 8006020 [TBL] [Abstract][Full Text] [Related]
12. Tissue-specific distribution of the Goodpasture antigen demonstrated by 2-D electrophoresis and western blotting. Derry CJ; Pusey CD Nephrol Dial Transplant; 1994; 9(4):355-61. PubMed ID: 8084446 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a non-Goodpasture autoantibody to type IV collagen. Johansson C; Butkowski R; Swedenborg P; Alm P; Wieslander J Nephrol Dial Transplant; 1993; 8(11):1205-10. PubMed ID: 8302456 [TBL] [Abstract][Full Text] [Related]
14. Identification of the Goodpasture antigen, alpha 3(IV) NC1, and four other NC1 domains of type IV collagen, by amino-terminal sequence analysis of human glomerular basement membrane separated by two-dimensional electrophoresis. Derry CJ; Pickering M; Baker C; Pusey CD Exp Nephrol; 1994; 2(4):249-56. PubMed ID: 7520821 [TBL] [Abstract][Full Text] [Related]
15. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis. Thorner PS; Baumal R; Eddy A; Marrano P Clin Nephrol; 1989 Mar; 31(3):160-8. PubMed ID: 2706812 [TBL] [Abstract][Full Text] [Related]
17. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Brainwood D; Kashtan C; Gubler MC; Turner AN Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224 [TBL] [Abstract][Full Text] [Related]
18. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition. Ryan JJ; Mason PJ; Pusey CD; Turner N Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978 [TBL] [Abstract][Full Text] [Related]
19. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Yang R; Cui Z; Hellmark T; Segelmark M; Zhao MH; Wang HY Clin Immunol; 2007 Aug; 124(2):207-12. PubMed ID: 17556023 [TBL] [Abstract][Full Text] [Related]
20. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen. Kleppel MM; Kashtan C; Santi PA; Wieslander J; Michael AF Lab Invest; 1989 Sep; 61(3):278-89. PubMed ID: 2671490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]